The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine

PMID: 13067200Aug 1, 1953

The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine

Circulation

E D FREISE A PARTENOPE

Abstract

No abstract listed.

References

The hemodynamic effects of hypotensive drugs in man. III. Hexamethonium

Dec 1, 1953·The Journal of Clinical Investigation·E D FREISR L JOHNSON

Suppression of vasomotor reflexes in man following L-hydrazinophthalozine (C-5968)

Oct 1, 1950·Proceedings of the Society for Experimental Biology and Medicine·E D FREIS, F A Finnerty

Methonium compounds in the treatment of hypertension

Apr 14, 1951·British Medical Journal·S LOCKETW S M GRIEVE

Control of hypertension by hexamethonium and 1-hydrazinophthalazine; preliminary observations

Apr 1, 1952·A.M.A. Archives of Internal Medicine·H A SCHROEDER

The hemodynamic effects of hypotensive drugs in man; dihydroergocornine

Nov 1, 1949·The Journal of Clinical Investigation·E D FREIS, J R Stanton

A new group of hypotensive substances with a special mechanism of action

Jan 15, 1950·Experientia·F GROSSR MEIER

THE ESTIMATION OF HEPATIC BLOOD FLOW IN MAN

Nov 1, 1945·The Journal of Clinical Investigation·S E BradleyJ J Curry

THE HEMODYNAMIC EFFECTS OF HYPOTENSIVE DRUGS IN MAN. I. VERATRUM VIRIDE

Mar 1, 1949·The Journal of Clinical Investigation·E D FREISR W WILKINS

Citations

Oxdralazine, a new peripheral vasodilator, combined with propranolol and hydrochlorothiazide: a rational approach to antihypertensive treatment

Nov 1, 1979·Journal of Clinical Pharmacology·E BartoliG Soggia

The clinical pharmacology of tolmesoxide. A new vasodilator antihypertensive agent

Jan 1, 1982·European Journal of Clinical Pharmacology·C P O'BoyleJ G Kelly

Combination therapy of essential hypertension with pindolol (Visken) and hydralazine

Dec 19, 1975·European Journal of Clinical Pharmacology·I Persson

RESPONSES OF THE HEPATIC CIRCULATION TO VARIOUS PHARMACOLOGIC AGENTS: A REVIEW

Mar 1, 1965·The American Journal of Digestive Diseases·A D Bender, S M HORVATH

The cardiorenal hemodynamic effects of antihypertensive therapy with reserpine

Nov 1, 1962·American Heart Journal·C S REUSCH

Current concepts in treatment of hypertensive urgencies

Jan 1, 1986·American Heart Journal·R J Anderson, W G Reed

Protective effects of hydralazine in a renal ischemia model in the rat

Aug 3, 1987·Life Sciences·R A VergonaL Rosenberger

Multi-organ functional imaging with thallium-201: a new noninvasive method for rapid assessment of vasoactive drugs

Nov 1, 1982·Journal of Pharmacological Methods·P GachonJ Maublant

Calcium, drug action and hypertension

Jan 1, 1983·Pharmacology & Therapeutics·S Lipe, R F Moulds

In vitro modulation of macrophage functions by 1,1-dimethylhydrazine (UDMH): Possible mechanism for UDMH-induced immuno-enhancement

Jan 1, 1988·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M J TarrR H Fertel

Antihypertensive agents. II. Benzothiadiazine compounds, rauwolfia and hydralazine

Mar 22, 1962·The New England Journal of Medicine·E D FREIS

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade

Mar 23, 1972·The New England Journal of Medicine·R ZacestJ Koch-Weser

Medical intelligence drug therapy

Aug 5, 1976·The New England Journal of Medicine·J Koch-Weser

Rebound hemodynamic events after the abrupt withdrawal of nitroprusside in patients with severe chronic heart failure

Nov 29, 1979·The New England Journal of Medicine·M PackerM V Herman

Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol

Jul 1, 1979·British Journal of Clinical Pharmacology·I B DaviesT Rosenthal

Inhibition by hydralazine of the conversion of dopamine to noradrenaline in rat atria in vitro and in vivo

Sep 1, 1980·Clinical and Experimental Pharmacology & Physiology·P SongkittigunaM J Rand

The vasodilator--beta-blocker interaction--some determinants of its clinical success

Aug 1, 1976·Australian and New Zealand Journal of Medicine·R Zacest

The use of radioactive microspheres to compare the effects of hydralazine, guanethidine and SK & F 24260 on the redistribution of cardiac output in anaesthetized rabbits

Nov 1, 1975·British Journal of Pharmacology·B M Johnson

Drug Treatment of Hypertension

Jun 19, 1954·British Medical Journal

Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure

Sep 1, 1980·British Heart Journal·W R Ginks, D R Redwood

Influence of dihydralazine induced afterload reduction on systolic time intervals and echocardiography in healthy subjects

Oct 1, 1984·British Heart Journal·H C SternG G Belz

Metabolism of hydralazine

Jan 1, 1977·Drug Metabolism Reviews·Z H Israili, P G Dayton

Changes in control of renin release in congestive heart failure in dogs: response to acute and chronic vasodilator therapy

Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·R L EnglerJ W Covell

Cardiovascular effects of isoxsuprine and sotalol

Sep 1, 1973·Journal of Pharmaceutical Sciences·G J Kelliher, S P Shanor

Direct and reflex cardiostimulating effects of hydralazine

Jul 1, 1977·The American Journal of Cardiology·I KhatriE D FREIS

HYDRALLAZINE

Feb 12, 1977·Lancet

Differential systemic arterial and venous actions and consequent cardiac effects of vasodilator drugs

Mar 1, 1982·Progress in Cardiovascular Diseases·R R MillerM A Quinones

Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man

Sep 1, 1971·The American Journal of Cardiology·R SannerstedtL Werkö

Pharmacology and clinical use of hydralazine in the treatment of diastolic hypertension

Jun 1, 1962·The American Journal of Cardiology·A SCHIRGER, J A SPITTELL

Echocardiographic assessment of the effect of an antihypertensive regimen on left ventricular performance

Mar 1, 1979·The American Journal of Cardiology·J P MoyerJ W Woods

Cardiovascular clinical pharmacology of impedance reducing agents

Jan 1, 1981·Journal of Chronic Diseases·J A Franciosa, G Pierpont

Survival in hydralazine-treated hypertensive patients with and without late toxicity

Aug 1, 1977·Journal of Chronic Diseases·H M PerryE F Perry

Hydralazine and related compounds: chemistry, metabolism, and mode of action

Jan 1, 1981·Medicinal Research Reviews·P A Reece

Acute haemodynamic effects of pinacidil in man

Sep 1, 1986·British Journal of Clinical Pharmacology·D P NichollsR G Shanks

The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man

Feb 1, 1988·British Journal of Clinical Pharmacology·R F JeffreyM R Lee

Antihypertensive drugs and baroreceptor reflex control of heart rate and blood pressure

Jan 1, 1987·Fundamental & Clinical Pharmacology·A Berdeaux, J F Giudicelli

The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutolol

Jan 1, 1982·Biopharmaceutics & Drug Disposition·D B JackM E Tenneson

Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension

Apr 1, 1985·The American Journal of Cardiology·H O VenturaM B Kardon

Renal pharmacodynamics of antihypertensive drugs: clinical applications

May 1, 1966·The American Journal of Cardiology·G Onesti

The comeback of hydralazine

Jan 1, 1978·American Heart Journal·J Koch-Weser

Hydralazine in the management of chronic congestive heart failure

Jun 1, 1985·The American Journal of Cardiology·R Rosenblum

Gastric secretion and anticholinergic drugs

Mar 1, 1968·The British Journal of Surgery·D T Caridis, G Smith

Discriminative stimulus properties of the vasodilator, hydralazine: differential generalization with alpha 1 and alpha 2 adrenoreceptor drugs

Jan 1, 1982·Progress in Neuro-psychopharmacology & Biological Psychiatry·D A Bennett, H Lal

The problem of the moderate to severe hypertensive patient

Jun 1, 1976·Angiology·F A Finnerty

The hemodynamics of hypertension and antihypertensive therapy

Sep 1, 1966·Angiology·A D Bender

Effect of diazoxide on capacitance vessels

Jul 30, 1978·European Journal of Clinical Pharmacology·J BahlmannM Cachovan

Hydralazine for essential hypertension

Nov 11, 2011·The Cochrane Database of Systematic Reviews·Michael R KandlerDouglas M Salzwedel

Oral hydralazine therapy for chronic refractory heart failure

Dec 1, 1976·Circulation·K ChatterjeeA Norman

The effects of hexamethonium on certain manifestations of congestive heart failure

Feb 1, 1953·Circulation·R T KELLEYT F HIGGINS

Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure

Mar 1, 1982·Circulation·R D MagorienC V Leier

Arterial dilators in mitral regurgitation: effects on rest and exercise hemodynamics and long-term clinical follow-up

Jan 1, 1982·Circulation·B H GreenbergS Rahimtoola

Hemodynamic studies of a monoamine oxidase inhibitor, DL-serine-N2-isopropylhydrazide (RO 4-1038). Mechanism of hypotensive action

Dec 1, 1962·Circulation·M H MAXWELLC R KLEEMAN

Changes in plasma renin activity and haemodynamics during vasodilator therapy in conscious dogs with myocardial infarction or chronic volume overload

Aug 1, 1983·European Journal of Clinical Investigation·H PouleurJ W Covell

Protection against acute trauma and traumatic shock by vasodilators

Oct 1, 1959·Canadian Journal of Biochemistry and Physiology·M NICKERSON, S A CARTER

Beneficial effects of hydralazine in severe mitral regurgitation

Aug 1, 1978·Circulation·B H GreenbergK Chatterjee

Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency

Jul 1, 1980·Circulation·B H GreenbergS Rahimtoola

Hydralazine in chronic CHF

Jan 1, 1981·Acta Medica Scandinavica. Supplementum·K ChatterjeeB M Massie

The effects of hydralazine administered into the brachial artery on adrenergic vasoconstrictor stimuli in the hand

Jan 1, 1962·Acta Pharmacologica Et Toxicologica·B ABLADM HENNING

Effect of hypotensive drugs on stroke volume and vascular resistance in hypertension. II. Reserpin (Serpasil-Ciba) and its combination with Nepresol

Mar 1, 1954·Klinische Wochenschrift·H SCHUMANN

Hemodynamic effects of combined beta-adrenoceptor blockade and precapillary vasodilatation in hypertension

Jan 1, 1985·Acta Medica Scandinavica. Supplementum·R EggertsenL Hansson

Direct Vasodilators and Sympatholytic Agents

Jun 3, 2015·Journal of Cardiovascular Pharmacology and Therapeutics·Meghan N McCombTien M H Ng

COMPARATIVE EFFECTS OF INTRA-ARTERIALLY ADMINISTERED HYDRALAZINE AND SODIUM NITRITE ON BLOOD FLOW AND VOLUME OF FOREARM

Jan 1, 1963·Acta Pharmacologica Et Toxicologica·B ABLAD, G JOHNSSON

Related Concepts

Blood Circulation

Sympatholytic Effect

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine

Abstract

References

The hemodynamic effects of hypotensive drugs in man. III. Hexamethonium

Suppression of vasomotor reflexes in man following L-hydrazinophthalozine (C-5968)

Methonium compounds in the treatment of hypertension

Control of hypertension by hexamethonium and 1-hydrazinophthalazine; preliminary observations

The hemodynamic effects of hypotensive drugs in man; dihydroergocornine

A new group of hypotensive substances with a special mechanism of action

THE ESTIMATION OF HEPATIC BLOOD FLOW IN MAN

THE HEMODYNAMIC EFFECTS OF HYPOTENSIVE DRUGS IN MAN. I. VERATRUM VIRIDE

Citations

Oxdralazine, a new peripheral vasodilator, combined with propranolol and hydrochlorothiazide: a rational approach to antihypertensive treatment

The clinical pharmacology of tolmesoxide. A new vasodilator antihypertensive agent

Combination therapy of essential hypertension with pindolol (Visken) and hydralazine

RESPONSES OF THE HEPATIC CIRCULATION TO VARIOUS PHARMACOLOGIC AGENTS: A REVIEW

The cardiorenal hemodynamic effects of antihypertensive therapy with reserpine

Current concepts in treatment of hypertensive urgencies

Protective effects of hydralazine in a renal ischemia model in the rat

Multi-organ functional imaging with thallium-201: a new noninvasive method for rapid assessment of vasoactive drugs

Calcium, drug action and hypertension

In vitro modulation of macrophage functions by 1,1-dimethylhydrazine (UDMH): Possible mechanism for UDMH-induced immuno-enhancement

Antihypertensive agents. II. Benzothiadiazine compounds, rauwolfia and hydralazine

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade

Medical intelligence drug therapy

Rebound hemodynamic events after the abrupt withdrawal of nitroprusside in patients with severe chronic heart failure

Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol

Inhibition by hydralazine of the conversion of dopamine to noradrenaline in rat atria in vitro and in vivo

The vasodilator--beta-blocker interaction--some determinants of its clinical success

The use of radioactive microspheres to compare the effects of hydralazine, guanethidine and SK & F 24260 on the redistribution of cardiac output in anaesthetized rabbits

Drug Treatment of Hypertension

Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure

Influence of dihydralazine induced afterload reduction on systolic time intervals and echocardiography in healthy subjects

Metabolism of hydralazine

Changes in control of renin release in congestive heart failure in dogs: response to acute and chronic vasodilator therapy

Cardiovascular effects of isoxsuprine and sotalol

Direct and reflex cardiostimulating effects of hydralazine

HYDRALLAZINE

Differential systemic arterial and venous actions and consequent cardiac effects of vasodilator drugs

Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man

Pharmacology and clinical use of hydralazine in the treatment of diastolic hypertension

Echocardiographic assessment of the effect of an antihypertensive regimen on left ventricular performance

Cardiovascular clinical pharmacology of impedance reducing agents

Survival in hydralazine-treated hypertensive patients with and without late toxicity

Hydralazine and related compounds: chemistry, metabolism, and mode of action

Acute haemodynamic effects of pinacidil in man

The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man

Antihypertensive drugs and baroreceptor reflex control of heart rate and blood pressure

The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutolol

Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension

Renal pharmacodynamics of antihypertensive drugs: clinical applications

The comeback of hydralazine

Hydralazine in the management of chronic congestive heart failure

Gastric secretion and anticholinergic drugs

Discriminative stimulus properties of the vasodilator, hydralazine: differential generalization with alpha 1 and alpha 2 adrenoreceptor drugs

The problem of the moderate to severe hypertensive patient

The hemodynamics of hypertension and antihypertensive therapy

Effect of diazoxide on capacitance vessels

Hydralazine for essential hypertension

Oral hydralazine therapy for chronic refractory heart failure

The effects of hexamethonium on certain manifestations of congestive heart failure

Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure

Arterial dilators in mitral regurgitation: effects on rest and exercise hemodynamics and long-term clinical follow-up

Hemodynamic studies of a monoamine oxidase inhibitor, DL-serine-N2-isopropylhydrazide (RO 4-1038). Mechanism of hypotensive action

Changes in plasma renin activity and haemodynamics during vasodilator therapy in conscious dogs with myocardial infarction or chronic volume overload

Protection against acute trauma and traumatic shock by vasodilators

Beneficial effects of hydralazine in severe mitral regurgitation

Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency

Hydralazine in chronic CHF

The effects of hydralazine administered into the brachial artery on adrenergic vasoconstrictor stimuli in the hand

Effect of hypotensive drugs on stroke volume and vascular resistance in hypertension. II. Reserpin (Serpasil-Ciba) and its combination with Nepresol

Hemodynamic effects of combined beta-adrenoceptor blockade and precapillary vasodilatation in hypertension

Direct Vasodilators and Sympatholytic Agents

COMPARATIVE EFFECTS OF INTRA-ARTERIALLY ADMINISTERED HYDRALAZINE AND SODIUM NITRITE ON BLOOD FLOW AND VOLUME OF FOREARM

Related Concepts

Related Feeds

Cardiology Journals

Related Papers

Hemodynamic effects of 1-hydrazinophthalazine in patients with arterial hypertension

Studies on hydralazine; evidence for a peripheral site of action